
Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis
Abstract Amyotrophic lateral sclerosis (ALS) is a fatal disease characterized by aberrant alternative splicing (AS). Nuclear loss and cytoplasmic accumulation of the splicing factor TDP-43